Back to All Events

International Ataxia Research Conference 2015


  • Beaumont Estate Windosr UK (map)

Retrotope, Inc., an emerging, clinical stage degenerative disease therapeutic company, gave a presentation at the International Ataxia Research Conference.  The talk entitled: “An upcoming clinical trial testing the safety and efficacy of a stabilized polyunsaturated fatty acid in Friedreich’s ataxia” elucidated the company’s progress towards an Investigational New Drug (IND) application for the fatal, orphan disease, Friedreich’s ataxia (FRDA).   Currently, there is no approved therapy for FRDA. See the News section for further details.

 

Earlier Event: February 2
2014 Gordon Research Conference